GODSEY & GIBB, INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
GODSEY & GIBB, INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$19,769,295
-0.6%
194,083
-1.6%
2.42%
+7.4%
Q2 2023$19,894,811
+6.2%
197,154
-3.2%
2.26%
+2.8%
Q1 2023$18,736,537
+12.1%
203,658
+6.5%
2.20%
-59.1%
Q4 2021$16,720,000
+10.6%
191,150
+3.4%
5.36%
-20.5%
Q3 2021$15,121,000
+0.4%
184,900
+5.0%
6.74%
+263.9%
Q1 2021$15,055,000
-6.8%
176,123
+2.9%
1.85%
-14.8%
Q4 2020$16,162,000
+12.1%
171,157
+3.2%
2.18%
+0.2%
Q3 2020$14,422,000
+0.1%
165,852
+0.5%
2.17%
-5.8%
Q2 2020$14,412,000
+5.2%
165,005
-0.7%
2.30%
-11.7%
Q1 2020$13,704,000
-13.7%
166,207
-0.9%
2.61%
+17.1%
Q4 2019$15,877,000
+11.3%
167,671
+2.2%
2.23%
+2.5%
Q3 2019$14,263,000
-3.7%
164,126
+1.2%
2.17%
+1.8%
Q2 2019$14,808,000
-0.7%
162,169
+4.6%
2.13%
-5.7%
Q1 2019$14,911,000
+17.0%
155,092
+4.5%
2.26%
-1.2%
Q4 2018$12,740,000
+2.4%
148,467
+2.8%
2.29%
+15.4%
Q3 2018$12,438,000
+24.5%
144,356
+9.2%
1.98%
+14.8%
Q2 2018$9,990,000
-15.6%
132,245
-9.7%
1.73%
-17.2%
Q1 2018$11,839,000
-0.9%
146,430
+2.9%
2.09%
+3.8%
Q4 2017$11,945,000
-2.9%
142,270
-0.7%
2.01%
-4.4%
Q3 2017$12,298,000
-2.2%
143,253
-4.9%
2.10%
-4.7%
Q2 2017$12,574,000
+15.2%
150,641
+2.5%
2.21%
+11.1%
Q1 2017$10,911,000
+3.1%
146,910
+1.1%
1.98%
+1.1%
Q4 2016$10,585,000
-7.2%
145,314
+0.6%
1.96%
-3.8%
Q3 2016$11,408,000
-0.0%
144,474
+4.5%
2.04%
-1.5%
Q2 2016$11,409,000
+18.2%
138,274
+3.8%
2.07%
+11.3%
Q1 2016$9,652,000
-12.3%
133,235
+4.2%
1.86%
-14.1%
Q4 2015$11,006,000
-5.2%
127,926
+1.3%
2.17%
-9.1%
Q3 2015$11,614,000
-10.5%
126,345
-4.2%
2.38%
+3.6%
Q2 2015$12,970,000
-5.3%
131,887
-5.0%
2.30%
-6.5%
Q1 2015$13,691,000
+3.6%
138,843
-2.6%
2.46%
+0.2%
Q4 2014$13,210,000
-1.8%
142,561
-0.2%
2.46%
-3.1%
Q3 2014$13,447,000
+2.0%
142,856
-1.9%
2.54%
+1.4%
Q2 2014$13,182,000
-4.0%
145,611
-9.9%
2.50%
-9.8%
Q1 2014$13,738,000
+2.6%
161,586
-3.0%
2.77%
+1.8%
Q4 2013$13,394,000
+7.4%
166,641
+2.5%
2.72%
-1.5%
Q3 2013$12,475,000
+10.8%
162,616
+2.1%
2.76%
+6.1%
Q2 2013$11,262,000159,2712.60%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders